4-Tert-Butylaniline → HCID 11677186, compound
Reaction equation
Cl[C:2]1[C:3]([C:8]2[CH:19]=[CH:18][C:11]3[C:12](O)=[N:13][S:14](=[O:16])(=[O:15])[C:10]=3[CH:9]=2)=[N:4][CH:5]=[CH:6][CH:7]=1.[NH2:20][C:21]1[CH:26]=[CH:25][C:24]([C:27]([F:30])([F:29])[F:28])=[CH:23][N:22]=1.C(C1C=CC(N)=CC=1)(C)(C)C>>[F:28][C:27]([F:30])([F:29])[C:2]1[C:3]([C:8]2[CH:19]=[CH:18][C:11]3[C:12]([NH:20][C:21]4[CH:26]=[CH:25][C:24]([C:27]([F:28])([F:30])[F:29])=[CH:23][N:22]=4)=[N:13][S:14](=[O:16])(=[O:15])[C:10]=3[CH:9]=2)=[N:4][CH:5]=[CH:6][CH:7]=1Participants
4
Procedure
The title compound was prepared using the procedure as described in Example 1C, substituting the product of Example 7B for the product of Example 1B, and substituting 2-amino-5-trifluoromethylpyridine for 4-tert-butylaniline. 1H NMR (300 MHz, CDCl3) δ 8.92 (d, 1H), 8.72 (d, 1H), 8.67 (s, 1H), 8.45 (brs, 1H), 8.15-8.19 (m, 2H), 8.11 (dd, 1H), 7.95 (d, 1H), 7.89 (d, 1H), 7.57 (dd, 1H). MS (m/z) 473.1.
Sources & evidence
- ORD record
- ord-1feb0d626cec4ceeb6bdb69c00972858
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07615570B2
Reaction notes
Loading…